A novel function for dendritic cell: Clearance of VEGF via VEGF receptor-1

Biochemical and Biophysical Research Communications

Volumn 380, Issue 2, 2009, Pages 243-248

  Xie, Yi ^a,c   Fan, Jianqing ^b   Chen, Juhua ^c   Huang, Fang Ping ^d   Cao, Brian ^e   Tam, Paul K H ^a   Ren, Yi ^a,f  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b PRINCETON UNIVERSITY   (United States)

^c LEGACY RESEARCH   (United States)

^d HAMMERSMITH HOSPITAL   (United Kingdom)

^e VAN ANDEL RESEARCH INSTITUTE   (United States)

^f RUTGERS UNIVERSITY   (United States)

Author keywords

DC; VEGF; VEGF receptor 1

Indexed keywords

CELL PROTEIN; MESSENGER RNA; NEUTRALIZING ANTIBODY; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ARTICLE; CANCER IMMUNOTHERAPY; CELL ACTIVITY; CELL FUNCTION; CULTURE MEDIUM; DENDRITIC CELL; ENDOCYTOSIS; INCUBATION TIME; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN SYNTHESIS;

CELL LINE, TUMOR; COMPOSITE RESINS; CULTURE MEDIA, CONDITIONED; DENDRITIC CELLS; ENDOCYTOSIS; HUMANS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 60349111039     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.01.043     Document Type: Article

References (34)

1. Carmeliet P., and Jain R.K. Angiogenesis in cancer and other diseases. Nature 407 (2000) 249-257
2. Dvorak H.F., Brown L.F., Detmar M., and Dvorak A.M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 146 (1995) 1029-1039
3. Bando H., Weich H.A., Brokelmann M., Horiguchi S., Funata N., Ogawa T., and Toi M. Association between intratumoral free and total VEGF, soluble VEGFR-1, VEGFR-2 and prognosis in breast cancer. Br. J. Cancer 92 (2005) 553-561
4. Salven P., Orpana A., Teerenhovi L., and Joensuu H. Simultaneous elevation in the serum concentrations of the angiogenic growth factors VEGF and bFGF is an independent predictor of poor prognosis in non-Hodgkin lymphoma: a single-institution study of 200 patients. Blood 96 (2000) 3712-3718
5. Zhang L., Yang N., Mohamed-Hadley A., Rubin S.C., and Coukos G. Vector-based RNAi, a novel tool for isoform-specific knock-down of VEGF and anti-angiogenesis gene therapy of cancer. Biochem. Biophys. Res. Commun. 303 (2003) 1169-1178
6. Ferrara N., Gerber H.P., and LeCouter J. The biology of VEGF and its receptors. Nat. Med. 9 (2003) 669-676
7. Sato Y., Kanno S., Oda N., Abe M., Ito M., Shitara K., and Shibuya M. Properties of two VEGF receptors, Flt-1 and KDR, in signal transduction. Ann. NY Acad. Sci. 902 (2000) 201-205 (discussion 205-7)
8. Kendall R.L., and Thomas K.A. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc. Natl. Acad. Sci. USA 90 (1993) 10705-10709
9. Park J.E., Chen H.H., Winer J., Houck K.A., and Ferrara N. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J. Biol. Chem. 269 (1994) 25646-25654
10. Clauss M., Weich H., Breier G., Knies U., Rockl W., Waltenberger J., and Risau W. The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J. Biol. Chem. 271 (1996) 17629-17634
11. Romani N., Gruner S., Brang D., Kampgen E., Lenz A., Trockenbacher B., Konwalinka G., Fritsch P.O., Steinman R.M., and Schuler G. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180 (1994) 83-93
12. Fernandez Pujol B., Lucibello F.C., Zuzarte M., Lutjens P., Muller R., and Havemann K. Dendritic cells derived from peripheral monocytes express endothelial markers and in the presence of angiogenic growth factors differentiate into endothelial-like cells. Eur. J. Cell Biol. 80 (2001) 99-110
13. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
14. Boissel N., Rousselot P., Raffoux E., Cayuela J.M., Maarek O., Charron D., Degos L., Dombret H., Toubert A., and Rea D. Defective blood dendritic cells in chronic myeloid leukemia correlate with high plasmatic VEGF and are not normalized by imatinib mesylate. Leukemia 18 (2004) 1656-1661
15. Della Porta M., Danova M., Rigolin G.M., Brugnatelli S., Rovati B., Tronconi C., Fraulini C., Russo Rossi A., Riccardi A., and Castoldi G. Dendritic cells, vascular endothelial growth factor in colorectal cancer: correlations with clinicobiological findings. Oncology 68 (2005) 276-284
16. Inoshima N., Nakanishi Y., Minami T., Izumi M., Takayama K., Yoshino I., and Hara N. The influence of dendritic cell infiltration and vascular endothelial growth factor expression on the prognosis of non-small cell lung cancer. Clin. Cancer Res. 8 (2002) 3480-3486
17. Brostjan C., Bayer A., Zommer A., Gornikiewicz A., Roka S., Benko T., Yaghubian R., Jakesz R., Steger G., Gnant M., Friedl J., and Stift A. Monitoring of circulating angiogenic factors in dendritic cell-based cancer immunotherapy. Cancer 98 (2003) 2291-2301
18. Ohm J.E., and Carbone D.P. VEGF as a mediator of tumor-associated immunodeficiency. Immunol. Res. 23 (2001) 263-272
19. Gabrilovich D.I., Chen H.L., Girgis K.R., Cunningham H.T., Meny G.M., Nadaf S., Kavanaugh D., and Carbone D.P. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat. Med. 2 (1996) 1096-1103
20. Osada T., Chong G., Tansik R., Hong T., Spector N., Kumar R., Hurwitz H.I., Dev I., Nixon A.B., Lyerly H.K., Clay T., and Morse M.A. The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients. Cancer Immunol. Immunother. 57 (2008) 1115-1124
21. Laxmanan S., Robertson S.W., Wang E., Lau J.S., Briscoe D.M., and Mukhopadhyay D. Vascular endothelial growth factor impairs the functional ability of dendritic cells through Id pathways. Biochem. Biophys. Res. Commun. 334 (2005) 193-198
22. Gabrilovich D., Ishida T., Oyama T., Ran S., Kravtsov V., Nadaf S., and Carbone D.P. Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood 92 (1998) 4150-4166
23. Oyama T., Ran S., Ishida T., Nadaf S., Kerr L., Carbone D.P., and Gabrilovich D.I. Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells. J. Immunol. 160 (1998) 1224-1232
24. Kiertscher S.M., Luo J., Dubinett S.M., and Roth M.D. Tumors promote altered maturation and early apoptosis of monocyte-derived dendritic cells. J. Immunol. 164 (2000) 1269-1276
25. Gille H., Kowalski J., Li B., LeCouter J., Moffat B., Zioncheck T.F., Pelletier N., and Ferrara N. Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants. J. Biol. Chem. 276 (2001) 3222-3230
26. Rahimi N., Dayanir V., and Lashkari K. Receptor chimeras indicate that the vascular endothelial growth factor receptor-1 (VEGFR-1) modulates mitogenic activity of VEGFR-2 in endothelial cells. J. Biol. Chem. 275 (2000) 16986-16992
27. Metezeau P., Elguindi I., and Goldberg M.E. Endocytosis of the membrane immunoglobulins of mouse spleen B-cells: a quantitative study of its rate, amount and sensitivity to physiological, physical and cross-linking agents. EMBO J. 3 (1984) 2235-2242
28. Heytler P.G., and Prichard W.W. A new class of uncoupling agents-carbonyl cyanide phenylhydrazones. Biochem. Biophys. Res. Commun. 7 (1962) 272-275
29. Thorstensen K. Hepatocytes and reticulocytes have different mechanisms for the uptake of iron from transferrin. J. Biol. Chem. 263 (1988) 16837-16841
30. Shuler R.L., and Owen C.S. Initiation of antigen receptor endocytosis and B lymphocyte activation lie on independent biochemical pathways. Immunol. Cell Biol. 71 Pt. 1 (1993) 1-11
31. Delva E., Jennings J.M., Calkins C.C., Kottke M.D., Faundez V., and Kowalczyk A.P. Pemphigus vulgaris IgG-induced desmoglein-3 endocytosis and desmosomal disassembly are mediated by a clathrin- and dynamin-independent mechanism. J. Biol. Chem. 283 (2008) 18303-18313
32. Le P.U., and Nabi I.R. Distinct caveolae-mediated endocytic pathways target the Golgi apparatus and the endoplasmic reticulum. J. Cell Sci. 116 (2003) 1059-1071
33. Kojic L.D., Joshi B., Lajoie P., Le P.U., Cox M.E., Turbin D.A., Wiseman S.M., and Nabi I.R. Raft-dependent endocytosis of autocrine motility factor is phosphatidylinositol 3-kinase-dependent in breast carcinoma cells. J. Biol. Chem. 282 (2007) 29305-29313
34. Ahmed A., Dunk C., Kniss D., and Wilkes M. Role of VEGF receptor-1 (Flt-1) in mediating calcium-dependent nitric oxide release and limiting DNA synthesis in human trophoblast cells. Lab. Invest. 76 (1997) 779-791